July 25, 2017 9:08 PM ET

Capital Markets

Company Overview of Clarus Ventures, LLC

Company Overview

Clarus Ventures, LLC is a venture capital and private equity firm specializing in investments in seed, start ups, early stage, mature, mid venture, late venture, growth capital, and PIPEs. It makes investments in life sciences sector with a focus on biopharmaceuticals, specialty pharma, medical device research equipments, biotechnology platforms or medical devices, and medical technology firms with products in development at value inflection points in their lifecycle. The firm prefers to invest in cancer drugs and treatments for inflammatory and urological disorders. It focuses on risk-shared, co-development of late-stage clinical assets and other structured financing opportunities. The firm...

101 Main Street

Suite 1210

Cambridge, MA 02142

United States

Founded in 2005





Key Executives for Clarus Ventures, LLC

Co-Founder and Managing Director
Age: 59
Managing Director
Age: 66
Managing Director
Age: 53
Managing Director
Age: 63
Co-Founder and Managing Director
Age: 64
Compensation as of Fiscal Year 2017.

Clarus Ventures, LLC Key Developments

Clarus Ventures, LLC Presents at 2nd Annual Neuroscience BioPartnering & Investment Forum, Mar-27-2017 09:30 AM

Clarus Ventures, LLC Presents at 2nd Annual Neuroscience BioPartnering & Investment Forum, Mar-27-2017 09:30 AM. Venue: 7 World Trade Center, 250 Greenwich St., 40th Floor (D Elevator Bank), The New York Academy of Sciences, New York, NY 10007, United States. Speakers: Kiran Reddy, Venture Partner.

Clarus Announces Executive Changes

Clarus announced the promotion of Emmett Cunningham, Jr. M.D., Ph.D., MPH to Managing Director, Barry Gertz M.D, PhD. to Partner, and Ari Brettman, M.D. to Principal. With more than 20 years of experience in the biomedical and biopharmaceutical sectors, Dr. Cunningham joined Clarus in 2006 from Eyetech Pharmaceuticals Inc. where he was the Senior Vice President of Medical Strategy. Dr. Gertz was promoted to Partner having joined Clarus as a Venture Partner in 2014 from Merck where he was Senior Vice President of Global Clinical Development, overseeing all aspects of Merck's clinical research. Dr. Gertz will continue in his role as Chief Physician Scientist at Nuvelution Pharma Inc. Dr. Brettman is a board observer for AvroBio and Entasis Therapeutics.

Clarus Ventures, LLC Presents at Boston CEO Conference, May-31-2016 09:10 AM

Clarus Ventures, LLC Presents at Boston CEO Conference, May-31-2016 09:10 AM. Venue: Four Seasons Boston, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Kiran Reddy.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States
123Jump.com, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

Private Placement
June 14, 2017
Tisbury Pharmaceuticals, Inc.
Private Placement
January 31, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Clarus Ventures, LLC, please visit www.clarusventures.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.